Cargando…

Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats

Chronic treatment with second-generation antipsychotic drugs (SGAs) has been associated with an increased risk of metabolic syndrome. To evaluate the longitudinal changes in glucose-lipid homeostasis after SGA use, we studied the time-dependent effects of olanzapine (OLZ) (3 mg/kg, b.i.d.) or clozap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xuemei, Wu, Zhixiang, Lian, Jiamei, Hu, Chang-Hua, Huang, Xu-Feng, Deng, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459828/ https://www.ncbi.nlm.nih.gov/pubmed/28584269 http://dx.doi.org/10.1038/s41598-017-02884-w

Ejemplares similares

Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
por: Lian, Jiamei, et al.
Publicado: (2014)

Disrupted sphingolipid metabolism following acute clozapine and olanzapine administration
por: Weston-Green, Katrina, et al.
Publicado: (2018)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Epigenetic Histone Methylation of PPARγ and CPT1A Signaling Contributes to Betahistine Preventing Olanzapine-Induced Dyslipidemia
por: Su, Yueqing, et al.
Publicado: (2023)

Effects of Olanzapine on Bone Mineral Density, Glucose, and Lipid Metabolism in Schizophrenia Patients
por: Liang, Mining, et al.
Publicado: (2019)

Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders
por: Mlambo, Ronald, et al.
Publicado: (2023)

Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy
por: Fang, Xinyu, et al.
Publicado: (2020)

Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatin
por: Liu, Xuemei, et al.
Publicado: (2020)

Cross-reaction of angioedema with clozapine, olanzapine, and quetiapine: A case report
por: Williams, Gabriela D.
Publicado: (2019)

Effect of alpha-mangostin on olanzapine-induced metabolic disorders in rats
por: Ardakanian, Alireza, et al.
Publicado: (2022)

Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine
por: Mier, Daniela, et al.
Publicado: (2018)

Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism
por: Medak, Kyle D., et al.
Publicado: (2023)

Meta-Analysis of the Efficacy and Safety of Olanzapine versus Clozapine when Treating Senile Dementia
por: Wang, Zongqin, et al.
Publicado: (2022)

Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: exploratory phase 1 results in healthy volunteers
por: Toledo, Frederico G. S., et al.
Publicado: (2021)

Dietary Supplementation of Vine Tea Ameliorates Glucose and Lipid Metabolic Disorder via Akt Signaling Pathway in Diabetic Rats
por: Xiang, Jiamei, et al.
Publicado: (2019)

Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
por: He, Sidi, et al.
Publicado: (2020)

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine
por: Tsuda, Yoshiyuki, et al.
Publicado: (2014)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
por: Merino, Diane, et al.
Publicado: (2022)

Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine
por: Bouhuis, Roos Hendrika, et al.
Publicado: (2022)

Retracted: Meta-Analysis of the Efficacy and Safety of Olanzapine versus Clozapine when Treating Senile Dementia
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Lipid and glucose metabolism in senescence
por: Liu, Bin, et al.
Publicado: (2023)

Curcumin Activates AMPK Pathway and Regulates Lipid Metabolism in Rats Following Prolonged Clozapine Exposure
por: Liu, Zhen, et al.
Publicado: (2017)

Effect of Intravenous Lipid Emulsion on Clozapine Acute Toxicity in Rats
por: Yousefsani, Bahareh Sadat, et al.
Publicado: (2019)

Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
por: Lu, Mong-Liang, et al.
Publicado: (2013)

Acute Metabolic Effects of Olanzapine Depend on Dose and Injection Site
por: Klingerman, Candice M., et al.
Publicado: (2015)

Effect of safranal, a constituent of saffron, on olanzapine (an atypical antipsychotic) induced metabolic disorders in rat
por: Malekzadeh, Sara, et al.
Publicado: (2019)

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
por: Manvich, Daniel F., et al.
Publicado: (2018)

Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia
por: Sathish Kumar, S. V., et al.
Publicado: (2015)

Roles of Twist1 in lipid and glucose metabolism
por: Huang, Liuyifei, et al.
Publicado: (2023)

Clozapine Induced Disturbances in Hepatic Glucose Metabolism: The Potential Role of PGRMC1 Signaling
por: Cao, Ting, et al.
Publicado: (2021)

The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT(7) receptors
por: Andressen, K W, et al.
Publicado: (2015)

Efficacy of Adjunctive Treatments Added to Olanzapine or Clozapine for Weight Control in Patients with Schizophrenia: A Systematic Review and Meta-Analysis
por: Choi, Yun-Jung
Publicado: (2015)

PM450. Effects of olanzapine, clozapine, risperidone and sertindole on FGF2, synapsin and NGF expression in the hippocampus of naive mice
por: Ulak, Guner, et al.
Publicado: (2016)

Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity
por: Sacchi, Silvia, et al.
Publicado: (2017)

Use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study
por: Jo, Young Tak, et al.
Publicado: (2021)

One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects
por: Ersland, Kari M, et al.
Publicado: (2019)

Dose-Dependent Olanzapine-Induced Myoclonus
por: Tikka, Sai Krishna, et al.
Publicado: (2014)

Clozapine Induced Insulin Dependence
por: McCalmon, Sean, et al.
Publicado: (2021)

Berberine Alleviates Olanzapine-Induced Adipogenesis via the AMPKα–SREBP Pathway in 3T3-L1 Cells
por: Li, Yanjie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rv3js36vasthsl1mlba5v1dpot